UPDATE 1-Impax buys generic drugs from Teva, Allergan for $586 mln
June 21, 2016 at 08:07 AM EDT
June 21 (Reuters) - Impax Laboratories Inc said it would buy a portfolio of generic drugs from Teva Pharmaceutical Industries Ltd and Allergan Plc for about $586 million.
